Infraredx sets the terms for its forthcoming initial public offering, which would fetch $59 million at the midpoint, and sets out on a road show to drum up interest from investors.
Infraredx today set the terms for its forthcoming initial public offering, saying it plans to offer 4 million shares at a range of $13 to $15 each, and set out on a road show to drum up interest from investors.
Royal Philips shares are down after the company said the slower-than-expected return of an Ohio CT scanner plant will hit its 2014 results.
Office printer giant Lexmark International is buying a Canadian maker of medical imaging software for $37 million.
A Kentucky company known more for its office laser printers is buying a Canadian producer of medical imaging software and technology, tapping into healthcare's growing reliance on digital content.
Carestream Health's Picture Archiving and Communications Systems (PACS) gets the nod from the U.S. Navy for use in its medical facilities across the globe.
Carestream Health is celebrating a new milestone that will help expand the use of its medtech imaging products in U.S. Naval medical facilities.
Intravascular imaging company Infraredx files for an initial public offering worth $55 million.
Infraredx yesterday registered for an initial public offering with the Securities & Exchange Commission, estimating the flotation's worth at $55 million.
Burlington, Mass.-based Infraredx makes an imaging system that combines intravascular ultrasound and near-infrared spectroscopy to provide images of the interior of coronary blood vessels.
Iradimed's stock shoots up nearly 15% on news that it can return to market with MRI-friendly intravenous infusion pump systems, which were pulled after an FDA inspection.
The FDA warns consumers about the health risks of so-called "keepsake" fetal ultrasound imaging and over-the-counter fetal heartbeat monitors.
The FDA wants to dissuade expecting parents from using unregulated fetal ultrasound devices to create "keepsake" images or monitor their babies' heartbeats at home, warning that the devices pose serious risks in untrained hands.